Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HC Surgical SpecialistsSGX:1B1 +1.45%63 Days Payable is 418.61 as of May. 2026, which is 1607% above its 10-year median of 24.53. GuruFocus rates SGX:1B1 with a GF Score™ of 63/100 and a GF Value™ of S$0.30 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, HC Surgical Specialists ranks better than 84.21% on this metric.
The historical rank and industry rank for HC Surgical Specialists's Days Payable or its related term are showing as below:
SGX:1B1'
s Days Payable Range Over the Past 10 Years
Min: 9.74 Med: 24.53 Max: 417.51
Current: 285.02
During the past 13 years, HC Surgical Specialists's highest Days Payable was 417.51. The lowest was 9.74. And the median was 24.53.
SGX:1B1's Days Payable is ranked better than 84.21% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.005
vs SGX:1B1: 285.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SGX:1B1 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, HC Surgical Specialists's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HC Surgical Specialists Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, HC Surgical Specialists's Days Payable distribution charts can be found below:
* The bar in red indicates where HC Surgical Specialists's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
HC Surgical Specialists's Days Payable for the fiscal year that ended in May. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HC Surgical Specialists (SGX:1B1) has a Days Payable of 418.61 as of May. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HC Surgical Specialists and its competitors. This is 1607% above median its historical median of 24.53. Over the past decade, HC Surgical Specialists' Days Payable has ranged from 9.74 to 417.51. According to the industry distribution chart, HC Surgical Specialists ranks #30 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 15.8%.
Is HC Surgical Specialists' Days Payable too high?
HC Surgical Specialists' current Days Payable of 418.61 is 1607% above median its 10-year median of 24.53. Over the past 10 years, this metric has ranged from a low of 9.74 to a high of 417.51. The Medical Diagnostics & Research industry median Days Payable is 65.01. HC Surgical Specialists' value of 418.61 is 544% above this industry median. Based on the distribution chart, HC Surgical Specialists ranks #30 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, HC Surgical Specialists has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HC Surgical Specialists' Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, HC Surgical Specialists ranks #30 out of 190 companies for Days Payable. This places HC Surgical Specialists in the top 16% of its industry — outperforming the majority of peers. The industry median Days Payable is 65.01. HC Surgical Specialists' value of 418.61 is 544% above this benchmark. Historically, HC Surgical Specialists' own Days Payable has ranged from 9.74 to 417.51 over the past decade. While the company's 10-year median is 24.53 vs. the industry median of 65.01, HC Surgical Specialists has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.01, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HC Surgical Specialists's current Days Payable of 418.61 is 544% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HC Surgical Specialists and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HC Surgical Specialists's current Days Payable is 418.61, which is 1607% above median its own 10-year median of 24.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HC Surgical Specialists stock overvalued right now?
Based on GuruFocus' analysis, HC Surgical Specialists (SGX:1B1) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.30, compared to a current price of S$0.35 — trading 16.7% above its estimated fair value. The current Days Payable is 418.61, which is 1607% above median its 10-year median of 24.53 and 544% above the Medical Diagnostics & Research industry median of 65.01. HC Surgical Specialists' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For HC Surgical Specialists (SGX:1B1), the current Days Payable is 418.61 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HC Surgical Specialists (SGX:1B1) Overvalued in 2026?
Based on GuruFocus' analysis, HC Surgical Specialists stock appears to be overvalued.
The current stock price of S$0.35 is trading 16.7% above its estimated GF Value™ of S$0.30.
GuruFocus considers HC Surgical Specialists to be Modestly Overvalued.
Key valuation signals for SGX:1B1:
Days Payable: 418.61 (1607% above median its 10-year median of 24.53)
GF Value™: S$0.30 vs. price of S$0.35 (16.7% above fair value)
Industry Position: 544% above the Medical Diagnostics & Research median (#30 of 190)
No single metric tells the full story. See the SGX:1B1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HC Surgical Specialists Ltd is a medical services group. The company is engaged in providing endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services. The operating segment of the company is the healthcare segment. Geographically, it operates only in Singapore. The company has its facilities center and clinics at various places in Singapore.
63GF Score
Get the complete analysis for SGX:1B1
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:1B1 has been successfully added to your 
